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John R. Wingard,1 I-Chan Huang,1
Kathleen A. Sobocinski,2 Michael A. Andrykowski,3 David Cella,4
J. Douglas Rizzo,2 Marianne Brady,5 Mary M. Horowitz,2 Michelle M. Bishop1Hematopoietic cell transplantation (HCT) is an intensive treatment for hematologic malignancies that has the
potential to cure disease or prolong life, but also to impair quality of life for survivors. Earlier studies have
suggested that various factors are associated with physical and mental health after HCT. In this study, we eval-
uated demographic and clinical factors before and after HCT and selected psychosocial factors after HCT,
exploring their association with self-reported physical and mental health. We studied a cohort of 662 survi-
vors at a median of 6.6 years after HCT. Pre-HCT demographic and clinical factors accounted for only a small
amount of the variance in physical and mental health post-HCT (3% and 1%, respectively). Adding post-HCT
clinical variables to the pre-HCT factors accounted for 32% and 7% of physical and mental outcomes, respec-
tively. When both clinical and psychosocial factors were considered, better physical health post-HCTwas
associated with younger age, race other than white, higher current family income, currently working or being
a student, less severe transplantation experience (ie, not experiencing graft-versus-host disease), fewer cur-
rent comorbidities, higher Karnofsky status, less social constraint, less social support, and less trait anxiety.
This multivariate model accounted for 36% of the variance in physical health, with the psychosocial variables
contributing very little. When both clinical and psychosocial factors were considered, better mental health
after HCTwas associated with more severe transplantation experience, less social constraint, greater spir-
itual well being, and less trait anxiety. This multivariate model accounted for 56% of the variance in mental
health, with the psychosocial factors accounting for most of the variance. These data suggest that clinical fac-
tors are explanatory for much of the post-HCT physical health reported by HCT survivors, but very little of
self-perceived mental health. These observations provide insight into the identification of factors that can
allow recognition of at-risk patients, as well as factors amenable to intervention.
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As survival rates have increased with improved can-
cer treatments, more attention has turned to the quality
of life (QoL) of survivors. Disease and treatment both
have the potential to affect the physical and emotional
status of long-term survivors. The presence of comor-
bid medical conditions and psychosocial factors also
may influence outcomes. Psychosocial factors, such as
personality traits or social support, also have the poten-
tial to affect, buffer, or modify self-perceived QoL.
Hematopoietic cell transplantation (HCT) is
a highly intensive therapy for hematologicmalignancies
and some solid tumor cancers. Earlier studies have sug-
gested that several factors are associated with overall,
physical, and emotional health-related QoL after
HCT: age at transplantation [1-9], employment status
Biol Blood Marrow Transplant 16:1682-1692, 2010 1683Self-Reported Physical and Mental Health after HCTat transplantation [1], sex [1,3,7,10,11], educational
status [5,7], marital status [1,12,13], family function at
time of transplantation [12,13], social support [13,14],
pre-HCTQoL [14,15], higher medical risk [14], trans-
plant type [2,9,14], intensity of the conditioning
regimen [5], time after transplantation [1,3,7,11],
development of acute or chronic graft-versus-host dis-
ease (aGVHD, cGVHD) [3,9,12,14-16], osteoporosis
or other sequelae [3,11,16], need for continued
medications [16], and relapse [16]. For children, family
functioning and individual resources, such as optimism
and social skills, socioeconomic status, andmore inten-
sive therapy, were important, whereas age [17] and sex
were not [18]. In various studies, the influences of
such factors, including intensity of conditioning regi-
men [19], were inconstant. In parallel, a study of leuke-
mia survivors who did not undergo transplantation
found that sex and education influenced QoL [10].
The inconsistency of the findings across studies might
result frommethodological shortcomings, such as small
sample size, use of convenience samples, variability in
case mix at single centers, and use of different instru-
ments to assess the outcomes of interest.
Using a large, randomly selected, stratified sample
of HCT survivors, we examined patient, clinical, dis-
ease, and treatment factors both before and after
transplantation to identify factors associated with
physical and mental health outcomes.We also assessed
post-HCT psychosocial factors to determine their
relative contributions to these outcomes. Our goal
was to identify such risk factors that would allow recog-
nition of at-risk patients and those factors amenable to
intervention to facilitate the development and imple-
mentation of clinical interventions to enhance QoL,
targeting those HCT recipients most vulnerable for
poor posttransplantation QoL.PATIENTS AND METHODS
Patients
Patients were randomly selected from eligible sur-
vivors at 40 centers participating in data reporting to
the Center for International Blood and Marrow
Transplant Research (CIBMTR). Patients had to be
at least 18 years old at time of transplantation, received
a myeloablative conditioning regimen, received no
more than one transplantation, alive free of relapse at
least 1 year after transplantation, able to read or write
English, and undergone transplantation for acute leu-
kemia, lymphoma, chronic myelogenous leukemia
(CML), or breast cancer. Eligible survivors were strat-
ified by disease, transplant type, number of years post-
transplantation, and intensity of previous therapy. The
data for this analysis were collected as part of a large
multicenter study of the long-term QoL of cancer/
HCT survivors, and these analyses have not beenreported previously. Results describing the QoL of
the survivors compared with controls were described
previously, including details of survivor characteris-
tics, study procedures, and institutional review board
approval [20,21], as well as the experiences of
spouses [22]. This report focuses on determining
what factors might influence the physical and emo-
tional outcomes of the survivors. Patient characteris-
tics are summarized in Table 1.METHODS
After informed consent was obtained, data were
collected by written questionnaire and computer-
assisted telephone interview, as described previously
[20]. Various patient, disease, psychological, social,
and treatment factors were examined to determine
their association with the outcomes of physical and
emotional well being. Some of the factors were
assessed at time of HCT, others were assessed after
HCT at the time of QoL assessment, and some were
assessed at both time points.
Outcomes Assessed
Self-reported physical health wasmeasuredwith the
PhysicalComponent Summary (PCS) score of theMed-
ical Outcomes Study (MOS) 36-Item Short Form
Health Survey (SF-36) [23]. Self-reportedmental health
was assessed using the Mental Component Summary
(MCS) summary score of the SF-36. Demographic
data elicited included age atHCT, sex, race, andmarital
status, occupational status, family income, typeof health
insurance, andeducational level at the timeof the survey.
Comorbid conditions present before and after trans-
plantation were derived from data reported to the
CIBMTR and were categorized post hoc using the
Hematopoietic Cell Transplant–Comorbidity Index
(HCT-CI) scale as a framework [24,25]. Because the
assessed severity of the condition could not be
consistently determined from the reports, comorbid
conditions were categorized as either present or not
present. After transplantation, any comorbid conditions
that could be attributable to GVHD were deleted,
because they were considered part of GVHD, which
was assessed separately. Karnofsky performance status
was assessed by the clinical transplantation team at the
time of the study [26].
Disease factors included the type of disease and in-
tensity of previous therapy. Patients were assigned to
one of two categories of pretransplantation treatment
intensity based on the status and duration of their
disease before transplantation. The less-intense treat-
ment group included patients who underwent trans-
plantation for chronic-phase CML within 1 year of
diagnosis, acute leukemia or lymphoma infirst complete
remission, or adjuvant treatment of high-risk stage II or
Table 1. Clinical, Disease, and Transplant Characteristics
Pre-HCT and Post-HCT
Variable n Distribution, %
Demographic and clinical factors at time of transplantation
Patient factors
Age, years 662
Mean (SD) 42.1 (11)
Median (range) 42.4 (18-71)
<35 182 28
35-39 95 14
40-44 106 16
45-49 120 18
>50 159 24
Sex
Male 411 62
Female 251 38
Race
White 603 92
Other 56 8
Marital status 655
Married/living with
partner/committed
493 75
Other 162 25
Clinical factors
Comorbid conditions
(dichotomized as present
or not)
104 16
Malignant disease at initial
diagnosis, n (%)
Acute leukemia (acute
myelogenous leukemia or
acute lymphoblastic leukemia)
243 37
Chronic leukemia 131 20
Breast cancer 156 24
Lymphoma (Hodgkin disease
or non-Hodgkin lymphoma)
132 20
Intensity of treatment before HCT
Less intense 441 67
More intense 221 33
Type of transplant
Allogeneic 272 41
Autologous 390 59
Total body irradiation in
transplantation conditioning
regimen
235 56
Demographic and clinical factors after transplantation at the time
of the QoL interview
Patient factors
Education 658
High school or below 194 30
Some college or technical
education
209 32
College degree (BA/BS) 122 18
Education beyond bachelor’s
degree
133 20
Marital status 659
Married/living with
partner/committed
483 73
Other 176 27
Occupational status
Retired 75 11
Not working 100 15
Working or student 484 73
Family income
<$20,000 70 11
$20,000-40,000 141 22
$40,000-60,000 156 24
$60,000-80,000 100 15
>$80,000 181 28
Insurance status 597
Public 193 32
Private 387 65
No insurance 17 3
(Continued )
Table 1. (Continued )
Variable n Distribution, %
Clinical factors
Comorbid conditions 104 16
Severity of transplantation
experience
Low severity (autologous) 390 60
Intermediate severity
(allogeneic without
chronic GVHD)
168 26
High severity (allogeneic
with chronic GVHD)
88 14
Time since transplantation, years,
median (SD) (mean)
662 6.6 (3.1) (7.0)
Distance between transplant center
and residence, miles (SD)
600 148 (317)
HCT indicates hematopoietic cell transplantation; GVHD, graft-versus-
host disease.
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cluded those who underwent transplantation for
chronic-phase CML .1 year after diagnosis, acceler-
ated or blast-phase CML, acute leukemia or lymphoma
beyond first remission, or metastatic breast cancer. The
rationale was that patients with early-stage disease or
disease of shorter duration in general received less
therapy than those with more advanced or more long-
standing disease and were less likely to come to trans-
plantation with previous treatment-related toxicities.
Transplant factors included transplant type (autolo-
gous or allogeneic) and the severity of the transplanta-
tion experience. Transplantation treatment severity
was categorized as low severity (autologous transplant),
intermediate severity (allogeneic transplant without
cGVHD), or high severity (allogeneic transplant with
cGVHD). The distance between the transplant center
and the patient’s residence at the time of HCT and
time since transplantation were determined. The use
of TBI in the transplant conditioning regimen also
was assessed.
The following psychosocial factors were measured
at the time of assessment of QoL for this study. Social
supportwasmeasuredwith theDuke-UNCFunctional
Social Support Questionnaire [27]. Social constraint
(the degree to which participants feel constrained in
sharing their HCT-related thoughts and feelings with
others) was measured with the Social Constraints Scale
[28], Trait anxiety (a measure of an individual’s dispo-
sition for anxiety) was assessed by the Trait-Anxiety
subscale of the Spielberger State-Trait Anxiety Inven-
tory [29] at the time of study. Spiritual well being was
assessed using the Functional Assessment of Chronic
Illness Therapy-Spiritual Well-Being scale (FACIT-
Sp) [30]. The Life Orientation Test (LOT) was used
to assess the level of dispositional optimism [31].
Although trait anxiety and optimism were measured
at the same time as the QoL assessment, it could be
Table 2. QoL and Psychosocial Variables Measured at the
Time of the Survey
Biol Blood Marrow Transplant 16:1682-1692, 2010 1685Self-Reported Physical and Mental Health after HCTargued they have potential predictive power, because
they are considered enduring characteristics.Characteristic Mean Score SD Range
Psychosocial factors
Social constraint 25.2 8.7 16-60
Social support 32.0 7.0 8-40
Optimism 21.3 5.6 1-32
Trait anxiety 37.2 10.8 20-73
Spiritual well being 36.1 8.8 7-48
Self-reported physical and mental health
Physical health (PCS)* 44.5 11.6 6.4-64.5
Mental health (MCS)* 50.6 10.4 10.1-70.2
MCS indicatesmedical component score; PCS, physical component score.
*MCS and PCS are standardized scores, with 50 being normative.Data Analysis
We first conducted univariate analyses to investi-
gate the association of individual factors of interest
with the SF-36 PCS and MCS, followed by multivari-
ate analyses in which all significant factors were
included in the same models. We specifically investi-
gated whether the factors at time of HCT and the
factors at time of the study made different contribu-
tions to the SF-36 PCS and MCS, respectively.
Three different types of factors were investigated in
the analyses: demographic factors (ie, age andmarital sta-
tus at HCT, sex, race, and education level, occupational
status, family income, and health insurance at the time of
HCT and after HCT), clinical factors (ie, comorbidities
before and after HCT, type of malignant disease, inten-
sity of treatment before transplantation, type of trans-
plant, TBI in the transplantation conditioning regimen,
and severity of the transplantation experience), and
psychosocial factors assessed at the time of the study
(ie, social support, social constraint, trait anxiety, opti-
mism, and spiritual well being). The time since trans-
plantation and distance from the transplant center to
the patient’s residence were included as well.
For univariate analyses, t tests were performed to
investigate the associations of dichotomous factors
(eg, sex) with the SF-36 PCS and MCS, and analysis
of variance was used to investigate the associations of
categorical factors (eg, education) with the SF-36
PCS and MCS. For the categorical factors, the mean
scores of each pair of the categories were compared
using a Bonferroni correction for the P value. For con-
tinuous variables (eg, social support), Pearson’s corre-
lation coefficients were calculated to demonstrate their
association with SF-36 PCS and MCS.
For multivariate analyses, regression models were
performed using the ordinary least squares approach
by including variables that were statistically significant
in the univariate analyses. Three analytic models were
proposed to sequentially investigate the association of
each factor with the SF-36 PCS and MCS and its
changing association after accounting for other factors
in the model. Model 1 included demographic and clin-
ical factors before and at the time of HCT alone.
Model 2 included demographic and clinical factors
after HCT at the time of the study, in addition to
the factors included in model 1. Model 3 further in-
cluded psychological factors at the time of the study
in addition to the factors included in model 2.
All analyses were performed using the Stata 10.0
(StataCorp, College Station, TX). An alpha level\.05
was used to estimate the level of statistical significance.
No adjustment for multiple comparisons was made
because of the exploratory nature of this study.RESULTS
Descriptive Characteristics
Table 1 summarizes the various patient, clinical,
disease, and transplant characteristics at the time of
HCT and at the time of the study. Table 2 summarizes
descriptive statistics for the psychosocial variables and
the self-reported physical and mental health outcome
variables at the time of study, some of which have
been reported previously [20]. MCS and PCS scores
were not correlated with one another (r 5 0.13).
MCSandPCS are standardized scores; 50 is normative,
with 10 points in either direction equal to 1 standard
deviation (see http://www.sf-36.org/tools/sf36.shtml).
Thus, survivors’MCS scores were ‘‘normal‘‘ compared
with standard population and their PCS were lower,
but not by a full SD.Factors Associated with Current Self-Reported
Physical and Mental Health
Tables 3-5 describe the univariate associations of
demographic and clinical factors before and after
HCT (Tables 3 and 4, respectively) and psychosocial
factors (Table 5) with survivors’ physical and mental
health status. Better self-reported physical health was
associated with younger age, race other than white,
absence of comorbidities before or after HCT, less-
intensive previous therapy, autologous (rather than
allogeneic) transplant, higher current educational
attainment, currently working or attending school,
higher family income, having private (rather than pub-
lic) insurance, higher current Karnofsky score, and
less-severe transplantation experience. For pairwise
group comparisons, survivors aged\35 years reported
significantly better PCS compared with those aged
.50 years (adjusted P\ .005) (Table 3). For transplan-
tation experience, survivors with low and intermediate
severity reported significantly better PCS compared
with those with high severity (adjusted P \ .017)
(Table 4). Current psychosocial factors associated
with physical health included more social support,
Table 3. Associations of Patient, Clinical, Disease, and Transplant Factors Before Transplantation with Physical and Emotional
Status in Univariate Analyses
PCS MCS
Variable Mean Score F/t Test Mean Score F/t Test
Patient factors
Age, years
<35* 46.2 3.57‡ 49.7 2.31
35-39 45.3 49.7
40-44 45.0 50.8
45-49 44.4 50.0
>50* 41.7 52.7
Sex
Male 45.0 0.95 51.3 1.28
Female 44.2 50.2
Race
White 44.2 2.19† 50.6 0.49
Other 47.7 51.3
Marital status
Married/living with partner 44.7 0.75 50.7 0.05
Other 43.9 50.6
Clinical factors
Comorbid conditions
Yes 42.0 2.38† 48.7 2.10†
No 45.0 51.0
Disease factors
Malignant disease
Acute leukemia (acute myelogenous leukemia
or acute lymphoblastic leukemia)
44.2 0.51 50.2 0.46
Chronic myelogenous leukemia (CML) 44.0 50.6
Breast cancer 44.6 51.5
Lymphoma (Hodgkin disease or
non-Hodgkin lymphoma)
45.6 50.6
Intensity of treatment before HCT
Less intense 45.4 2.72‡ 50.6 0.01
More intense 42.8 50.6
Transplant factors
Type of transplant
Allogeneic 43.4 2.00† 50.4 0.58
Autologous 45.2 50.8
Total body irradiation in transplantation
conditioning regimen
Yes 43.4 1.80 50.3 1.02
No 45.1 51.2
HCT indicates hematopoietic cell transplantation; MCS, Medical Component Score; PCS, Physical Component Score.
*Pairwise comparison of mean scores among categories (subgroups) is statistically significant with Bonferroni correction for the P value.
†P < .05.
‡P < .01.
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lower trait anxiety, and greater spiritual well being.
Better self-reported mental health was associated
with absence of comorbidities before or after HCT,
(Table 5) currentlyworking, being in school orbeing re-
tired, higher family income, and higher Karnofsky
score. For pairwise group comparisons, survivors who
were not working reported more impaired MCS com-
pared with those who were retired or were working
(including students) (adjusted P\ .017). Survivors with
family income \$20,000 reported more impaired
MCS compared with those with family income of
$20,000-$40,000, $40,000-$60,000, $60,000-$80,000,
and.$80,000 (adjusted P\ .005) (Table 4). Psychoso-
cial factors associated with mental health included
more social support, less social constraint, greater dis-
positional optimism, lower trait anxiety, and greater
spiritual well being (Table 5).Multivariate Models of Variables That Account
for Variance in Self-Reported Physical Health
Table 6 summarizes 3 multivariate models devel-
oped for physical functioning. In model 1 (which exam-
ined demographic and clinical factors present before
HCT), we found that younger age (\40 years), race
other than white, and less-intensive previous therapy
were associated with better post-HCT physical health.
However, only 3% of the variance was explained by
thismodel. Inmodel 2 (which examined factors inmodel
1 plus demographic and clinical factors present after
HCT at the time of the study), we found race other
than white, higher family income ($$20,000), working
or being in school, less severe transplantation experience
(ie, absence of GVHD), absence of comorbidities at the
time of the study, and higherKarnofsky scorewere asso-
ciated with better physical health. This model explained
Table 4. Associations of Patient, Clinical, Disease, and Transplant Factors after Transplantation with Physical and Emotional Status
in Univariate Analyses
PCS MCS
Variable
Mean Score or Pearson’s
Correlation Coefficient F/t Test
Mean Score or Pearson’s
Correlation Coefficient F/t Test
Patient factors
Education
High school or below 42.5a 4.98** 49.9 0.54
Some college or technical education 43.8 51.2
College degree (BA/BS) 47.1a 50.8
Education beyond bachelor’s degree 46.0 50.7
Marital status
Married/living with partner/committed 44.9 1.61 51.1 1.81
Other 43.3 49.4
Occupational status
Retired 41.7b,d 74.63*** 54.6 18.25***
Not working 33.4b,c 45.7
Working or student 47.2c,d 51.1
Family income
<$20,000 36.0e,f,g,h 14.69*** 45.0 6.77***
$20,000-$40,000 42.8e 50.1
$40,000-$60,000 45.9f 51.8
$60,000-$80,000 47.0g 51.4
>$80,000 46.7h 51.9
Insurance status
Public 41.2 20.09*** 50.1 0.93
Private 45.8 51.0
Clinical factors
Comorbid conditions
Yes 36.0 8.62*** 48.4 2.44*
No 46.1 51.1
Karnofsky score† 0.40*** 0.14***
Severity of transplantation experience
Low severity (autologous) 45.2 17.21*** 50.8 0.21
Intermediate severity (allogeneic without chronic GVHD) 46.2 50.3
High severity (allogeneic with chronic GVHD) 38.0 50.3
Time since transplantation, years† 0.07 0.01
Distance between transplant center and residence, miles† 20.01 0.02
GVHD, graft-versus-host disease; MCS, Medical Component Score; PCS, Physical Component Score.
a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,pThe pairwise comparison of mean scores among the categories (subgroups) with common letters is statistically significant with Bon-
ferroni correction for P value.
*P < .05.
†Correlation coefficient.
**P < .01.
***P < .001.
Table 5. Association of Psychosocial Factors Assessed at the
Time of the Study with Physical and Emotional Well Being in
Univariate Analyses (Pearson’s Correlation Coefficients)
Factor
Correlation with
SF 36 PCS
Correlation with
SF 36 MCS
Biol Blood Marrow Transplant 16:1682-1692, 2010 1687Self-Reported Physical and Mental Health after HCTmuchmore of the variance, but it still accounted for only
32% of the variance. In model 3 (which examined the
psychosocial factors added to model 2), we found that
younger age (\35 years), race other than white, higher
family income ($$20,000), working or being in school,
less severe transplantationexperience, absenceof current
comorbidities, higher Karnofsky score, less social con-
straint, less social support, and less trait anxiety were
associated with better physical health. Thus, the inclu-
sion of psychosocial variables accounted for only an in-
cremental increase in variance (ie, the model explained
36% of the variance only 4%more than model 2).Social support 0.08* 0.47***
Social constraint 20.28*** 20.39***
Optimism 0.16*** 0.53***
Trait anxiety 20.23*** 20.71***
Spiritual well being 0.14*** 0.59***
*P < .05.
**P < .01.
***P < .001.Multivariate Models of Variables That Account
for Variance in Mental Health
Table 6 summarizes the 3 multivariate models for
self-reported mental health developed in the same
manner as described earlier. In model 1, older age
(.50 years compared with most age groups\50 years)and fewer comorbidities at the time of transplantation
were associated with greater emotional well being.
Only 1% of the variance was explained by this model,
however. In model 2, older age (.50 years compared
with most age groups \50 years), higher family
income ($$20,000), working being in school, and
Table 6. Series of Multivariate Regression Models Testing the Association of Demographic, Clinical, and Psychosocial Factors with
Posttransplantation Physical and Mental Health
PCS MCS
Factor Model 1 Beta Model 2 Beta Model 3 Beta Model 1 Beta Model 2 Beta Model 3 Beta
Demographic and clinical variables at time of HCT
Age at HCT, years (ref: >50)
<35 4.10** 2.21 2.89* 23.42** 22.90* 0.14
35-39 3.04* 0.62 2.05 23.43* 23.19* 20.71
40-44 2.82 1.41 2.41 22.31 22.16 0.67
45-49 2.05 1.78 2.15 23.11* 22.78* 20.70
Race (ref: white)
Other 3.32* 3.11* 3.09* 1.13 1.79 20.54
Intensity of previous treatment (ref: less)
More 22.35* 20.13 20.19 0.03 0.04 0.12
HCT comorbidities at HCT (ref: no)
Yes 22.22 0.98 1.00 22.85* 22.04 21.43
Demographic and clinical variables at time of study
Education at time of study (Ref: education
beyond bachelor’s degree)
High school or below 0.24 1.02 0.82 0.49
Some college or technical education 20.31 0.27 1.18 0.39
College degree 1.32 1.07 0.58 0.38
Family income at time of study (ref: >$80,000)
<$20,000 25.04** 24.15** 25.02** 20.83
$20,000-40,000 21.63 21.08 21.67 0.68
$40,000-60,000 20.31 20.39 20.12 0.92
$60,000-80,000 1.09 1.07 20.51 0.19
Occupational status at time of study
(ref: working or student)
Not working 28.35*** 27.51*** 22.98* 20.22
Retired 23.36* 23.72** 2.63 1.86
Severity of HCTexperience (ref: low-autologous)
Intermediate (allogeneic without chronic GVHD) 1.08 0.41 0.35 0.17
High (allogeneic with chronic GVHD) 22.56* 22.65* 1.45 2.10*
HCT comorbidities at time of study (ref: no)
Yes 26.62*** 26.62*** 20.97 0.39
Karnofsky score at last follow-up 0.28*** 0.28*** 0.11* 20.005
Psychological variables at time of study
Social constraint 20.27*** 20.11**
Spiritual well being 20.08 0.25***
Social support 20.19** 0.10
Trait anxiety 20.13* 20.47***
Adjusted R2 3% 32% 36% 1% 7% 56%
HCT indicates hematopoietic cell transplantation; MCS, Medical Component Score; PCS, Physical Component Score.
*P < .05.
**P < .01.
***P < .001.
1688 Biol Blood Marrow Transplant 16:1682-1692, 2010J. R. Wingard et al.higher Karnofsky or score were associated with better
emotional well being. This model explained only 7%
of the variance. In model 3, severe transplantation ex-
perience (ie, allogeneic HCT with cGVHD), less so-
cial constraint, greater spiritual well being, and lower
trait anxiety were associated with greater mental
health. This model explained 56% of the variance.DISCUSSION
Efforts to enhanceQoL are critical to the long-term
management of HCT recipients. However, enhancing
post-HCT QoL requires knowing not only those QoL
deficits likely to occur, but also risk factors for specific
QoL deficits. Identifying such risk factors can enhance
the theoretical understanding of how individuals adaptto life-threatening disease and treatment and, more
pragmatically, help focus clinical resources on those
patients at greatest risk for poor QoL.
Several demographic and clinical factors that are
readily available to transplant clinicians were found
to be significantly associated with long-term physical
and mental QoL. These included age, race, income,
intensity of transplantation experience, current work,
presence of comorbidities, and performance status.
For the most part, these factors are similar to those
identified in previous studies. Of note, younger age
(\35 years) was associated with better physical health,
whereas age did not influence mental health, similar to
findings in another study [9] that also found no decline
in social QoL with older age (and actually found an in-
crease in social QoL with older age). Surprisingly, race
other than white was associated with better physical
Biol Blood Marrow Transplant 16:1682-1692, 2010 1689Self-Reported Physical and Mental Health after HCThealth, but not with mental health. The number of mi-
nority transplantation survivors in this study (n 5 56,
mostly Hispanic and African American) was too small
to enable an exploratory analysis [32]. A similar finding
in solid organ transplantation survivors (the so-called
‘‘Hispanic paradox,‘‘ with better renal graft survival
in Hispanic transplant recipients) has been noted
[33]; this observation warrants further exploration in
future studies. The intensity of the transplantation
experience affected physical and mental health in
opposite ways. Not surprisingly, a more-intense trans-
plantation experience (ie, allogeneic HCT compli-
cated by chronic GVHD) was associated with poorer
physical health but, perhaps surprisingly, better
mental health. This is in contrast with other studies
that found an association between GVHD and poorer
physical, psychological, social, and spiritual QoL and/
or return to work using other measurement instru-
ments [9,13-15]. Those studies focused primarily on
early adaptation, in contrast to the present study with
a longer follow-up, and some studies that suggest full
recovery may take 3-5 years [14,34]. The explanation
for our findings is not obvious. The notion that
mastery over intense experiences confers benefits for
emotional well being and psychological growth is
a concept supported by other studies, including
another analysis of data from this study [21]. There
are other alternative possibilities, however. Subjects
with greater treatment or illness severity may change
their internal standard and use this new standard to de-
termine their perceptions of QoL, especially mental
aspects. A so-called ‘‘response shift‘‘ has been de-
scribed in cancer survivors [35]. Other studies suggest
that expectations might differ in patients receiving
more-intense therapy (ie, allogeneic HCT); patients
with more realistic expectations might be more accept-
ing of their limitations, because they were expecting
a rougher time [36,37]. Being ‘‘retired‘‘ had opposite
effects on physical and mental health; it was
associated with worse physical health, but there was
a trend toward better mental health. The explanation
for this is unclear.
Several notable differences between our findings
and those from previous studies should be mentioned.
Although some previous studies have found an associa-
tion between being married and better QoL [1,12,13],
we did not find this association. However, we did find
that social support and quality of the support (ie, less
social constraint) are quite important, as other studies
have noted [12-14]. These findings suggest that there
may be multiple sources of support (eg, from family or
friends) that might be as important as having a spouse.
Numerous other studies have reported an association
between sex and post-HCT QoL [1,3,7,10,11,14,31],
but we found no association between sex and either
physical or mental health.The demographic and clinical observations rou-
tinely monitored by transplantation practitioners
were moderately associated with self-reported physical
health. This association also was noted in self-reported
and practitioner-assessed Karnofsky scores [38] and
the presence of GVHD [9] in HCT survivors. How-
ever, demographic and clinical factors accounted for
very little of the variance in long-term mental health
(\10%). This emphasizes the independence of these
mental and physical health outcomes (r5 0.13). Other
studies have reported similar findings. For example,
one study found no association between transplant
type or cGVHDwith physical limitations, and no asso-
ciation between type of transplant or medical risks be-
fore transplantation with depression [14]. However,
other studies have suggested that allogeneic HCT
and especially cGVHD are associated with poorer
mental health [9,14,15,39].
For physical health, a combination of demo-
graphic and clinical factors before and after HCT
accounted for much more of the variance observed
(32%). The psychosocial assessments added little
additional value in explaining the variance of physical
QoL. Whether assessment of psychological variables
before HCT would be more useful in predicting
physical health as suggested by earlier studies [14], is
unclear. Of interest, race other than white was associ-
ated with greater physical health, but not with greater
mental health. The reason for this finding is unclear.
Also of interest is the seemingly anomalous finding
of an association between less social support and
greater physical health (in contrast to a lack of
association with greater mental health). Of note, the
coefficients are quite low, and in univariate analysis,
the association was in the opposite direction; this
suggests that a relationship with other factors in the
multivariate model might have influenced this find-
ing. This finding also suggests that the quality of
social interaction (as assessed by social constraint)
may be more important that the actual perceived
presence of social support. Of note, there was a corre-
lation between social support and social constraint
(r 5 20.43).
For mental QoL, neither demographic nor clinical
factors explained much of the variance (\10%).
Several social or psychological factors were highly
associated with better mental QoL and were of much
greater utility in explaining the mental QoL variance
(56%). Our results suggest that persons prone to
anxiety and experiencing social constraint from others
are at risk for poorer mental health outcomes. Fortu-
nately, these factors are amenable to intervention.
Several longitudinal studies of HCT QoL have sug-
gested that assessment of family and social support
[13,14] and mental health [15] can predict mental
health later after HCT.
1690 Biol Blood Marrow Transplant 16:1682-1692, 2010J. R. Wingard et al.Spiritual well being was associated with better men-
tal health. This emphasizes the potential usefulness of
including spiritual well being in assessment and treat-
ment planning considerations. Some surveys suggest
that the health care teamoftenunderestimates the extent
to which patients desire help in addressing spiritual
needs [40,41]; other studies indicate that such
interventions can improve physical, emotional, and
spiritual QoL [42-45]. Health practitioners can assist
with patients’ spiritual needs when setting goals and
planning treatment. The NCI’s ‘‘Spirituality in Cancer
Care‘‘website (http://www.cancer.gov/cancertopics/pdq/
supportivecare/spirituality/HealthProfessional/page6)
offers suggestions for intervention.
Although dispositional optimism was associated
with both physical andmental health in univariate anal-
yses, this association was not found in the multivariate
models. Optimism, a personal resource, mightmediate
the stress response; the expectation of a successful out-
come promotes active engagement and goal-striving
[46]. Low optimism has been associated with denial,
distancing, behavioral disengagement, and cognitive
avoidance [47,48]. In cancer patients, optimism has
been found to be related to lower distress through its
association with increased acceptance/active coping
[48]. This lack of association between optimism and
mental and physical health might result from an inter-
action with trait anxiety (r5 20.70).
This study has several important limitations. Most
notably, the data are retrospective, the psychosocial as-
sessments were obtained after HCT, and psychosocial
data were not collected at the time of transplantation.
Longitudinal studies have been important in probing
the utility of pre-HCT psychosocial assessments
[9,13-15], and a longitudinal study is a stronger
methodology to explore this; however, this type of
study has different limitations, including longer time
for completion, shorter follow-up, and higher dropout
rate. Although survivors were randomly selected from
a stratified list (by disease, type of transplant, time
since transplantation, and intensity of pre-HCT treat-
ment) of eligible survivors, only 74% could be con-
tacted, and 94% of those contacted participated [21].
Thus, the participants may differ from all HCT survi-
vors in unpredictable ways. These QoL assessments
represent snapshots in time, generally remote from
the actual HCT, as opposed to describing dynamic
QoL after HCT.Moreover, the survivors’ current per-
ceptions might be colored by their experiences after
transplantation. Finally, the psychosocial assessment
was limited in scope, and other psychosocial factors
not assessed may be as important or more important
to assess.
These data can be helpful to identify those at risk
for suboptimal outcomes. Our findings suggest that
demographic and clinical factors before and after
transplantation are explanatory for much of the post-HCT physical health reported by HCT survivors,
but very little of self-perceived mental health. The
findings also suggest an opposite relationship with
mental health scores, with most of the variance
accounted for by psychosocial variables, not by demo-
graphic or clinical variables. Given the importance of
achieving both good physical and mental health post-
HCT, equal weight should be given to assessing such
clinical and psychosocial variables to identify those
patients needing additional physical assistance and
mental support, and also to identify factors amenable
to change. Fortunately, several promising interven-
tions tested in non-HCT cancer patients can be appli-
cable to HCT survivors [49-57], and other potential
interventions are currently being evaluated in HCT
patients (eg, an exercise and stress management
intervention; BMTCTN.net, protocol 0902).ACKNOWLEDGMENTS
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